Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00360
|
|||||
| Drug Name |
Omadacycline
|
|||||
| Synonyms |
Amadacycline; Amadacycline (intravenous), Merck & Co; Amadacycline (intravenous), Paratek/Novartis; Amadacycline (oral), Merck & Co; Amadacycline (oral), Paratek/ Novartis; Antibacterial aminomethycyclines, Paratek/Bayer; MK-2764; Omadacycline; Omadacycline (intravenous), Merck & Co; Omadacycline (intravenous), Paratek; Omadacycline (intravenous), Paratek/ Novartis; Omadacycline (oral), Merck & Co; Omadacycline (oral), Paratek; Omadacycline (oral), Paratek/ Novartis; Omadacycline tosylate; P-000538; P-000642; P-001075; P-001207; P-001221; P-00136; P-002352; PTK-0796; PTK-796; Sancycline derivatives, Paratek; Tetracycline analogs, GlaxoSmithKline/Paratek; Tetracycline analogs, Paratek/Merck & Co;Tetracycline analogs (multi-drug-resistant infections), Paratek/Bayer
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Acute skin infections [ICD11: 1F28.Z] | Approved | [1] | |||
| Community-acquired bacterial pneumonia [ICD11: CA40.0Z] | Approved | [1] | ||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C29H40N4O7
|
|||||
| Canonical SMILES |
CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C
|
|||||
| InChI |
InChI=1S/C29H40N4O7/c1-28(2,3)12-31-11-14-10-17(32(4)5)15-8-13-9-16-21(33(6)7)24(36)20(27(30)39)26(38)29(16,40)25(37)18(13)23(35)19(15)22(14)34/h10,13,16,21,31,34-35,38,40H,8-9,11-12H2,1-7H3,(H2,30,39)/t13-,16-,21-,29-/m0/s1
|
|||||
| InChIKey |
VJYKVCURWJGLPG-IQZGDKDPSA-N
|
|||||
| CAS Number |
CAS 389139-89-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 556.6 | Topological Polar Surface Area | 177 | ||
| Heavy Atom Count | 40 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 10 | |||
| XLogP |
3
|
|||||
| PubChem CID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Omadacycline was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (ID: DB12455) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.